The Asia Hedge Fund 25 March 2, 2011 Related Articles Biopharma Funds Surge on Deals and Drug Breakthroughs Stephen Taub PivotalPath: Hedge Funds Post One of Their Best First Halves in Nearly Three Decades The Editorial Team The Hidden Margin Drain: Why Manual Data Operations Are Becoming Too Expensive to Ignore Sponsored by InterSystems